Related references
Note: Only part of the references are listed.Naturally occurring germline and tumor-associated mutations within the ATP-binding motifs of PTEN lead to oxidative damage of DNA associated with decreased nuclear p53
Xin He et al.
HUMAN MOLECULAR GENETICS (2011)
PTEN mutations and relationship to EGFR, ERBB2, KRAS, and TP53 mutations in non-small cell lung cancers
Guang Jin et al.
LUNG CANCER (2010)
Rak Functions as a Tumor Suppressor by Regulating PTEN Protein Stability and Function
Eun-Kyoung Yim et al.
CANCER CELL (2009)
The HECT-Type E3 Ubiquitin Ligase AIP2 Inhibits Activation-Induced T-Cell Death by Catalyzing EGR2 Ubiquitination
An Chen et al.
MOLECULAR AND CELLULAR BIOLOGY (2009)
Protein kinase DYRK2 is a scaffold that facilitates assembly of an E3 ligase
Subbareddy Maddika et al.
NATURE CELL BIOLOGY (2009)
The HECT family of E3 ubiquitin ligases: Multiple players in cancer development
Francesca Bernassola et al.
CANCER CELL (2008)
The PTEN/PI3K/AKT signalling pathway in cancer, therapeutic implications
Amancio Carnero et al.
CURRENT CANCER DRUG TARGETS (2008)
PTEN hamartoma tumor syndromes
Gideon M. Blumenthal et al.
EUROPEAN JOURNAL OF HUMAN GENETICS (2008)
Post-translational regulation of PTEN
X. Wang et al.
ONCOGENE (2008)
The ubiquitin ligase Nedd4-1 is dispensable for the regulation of PTEN stability and localization
Fatemeh Fouladkou et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Oocyte-specific deletion of Pten causes premature activation of the primordial follicle pool
Pradeep Reddy et al.
SCIENCE (2008)
In vivo functional analysis of the counterbalance of hyperactive phosphatidylinositol 3-kinase p110 catalytic oncoproteins by the tumor suppressor PTEN
Amparo Andres-Pons et al.
CANCER RESEARCH (2007)
Wwp2-mediated ubiquitination of the RNA polymerase II large subunit in mouse embryonic pluripotent stem cells
Hui Li et al.
MOLECULAR AND CELLULAR BIOLOGY (2007)
Cell survival, cell death and cell cycle pathways are interconnected: Implications for cancer therapy
Subbareddy Maddika et al.
DRUG RESISTANCE UPDATES (2007)
Ubiquitination regulates PTEN nuclear import and tumor suppression
Lloyd C. Trotman et al.
CELL (2007)
NEDD4-1 is a proto-oncogenic ubiquitin ligase for PTEN
Xinjiang Wang et al.
CELL (2007)
Pten dependence distinguishes haematopoietic stem cells from leukaemia-initiating cells
Omer H. Yilmaz et al.
NATURE (2006)
PI3K-Akt pathway: Its functions and alterations in human cancer
M Osaki et al.
APOPTOSIS (2004)
Wwp2, an E3 ubiquitin ligase that targets transcription factor Oct-4 for ubiquitination
HM Xu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Pten dose dictates cancer progression in the prostate
LC Trotman et al.
PLOS BIOLOGY (2003)
Ubiquitin-protein ligase WWP2 binds to and downregulates the epithelial Na+ channel
FJ McDonald et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2002)
PTEN protects p53 from Mdm2 and sensitizes cancer cells to chemotherapy
LD Mayo et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Haploinsufficiency of the Pten tumor suppressor gene promotes prostate cancer progression
B Kwabi-Addo et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Regulation of PTEN transcription by p53
V Stambolic et al.
MOLECULAR CELL (2001)